头发、血浆、红细胞中铅对评价职业性接触水平的作用

[目的]探讨发铅、血浆和红细胞中铅对评价职业性铅接触水平的作用。[方法]用原子吸收分光光度计测定接触铅组与不接触铅对照组工人的血浆、红细胞及发中铅、铁、铜、镁、钙含量，测量数据用SAS软件处理。[结果]用0．25mol／L的HCl处理发样，能有效去除发表面的铅污染。接触组与对照组血浆铅无显著差异，而红细胞铅、发铅差异显著，血中其他元素含量无显著差异。[结论]去除表面污染的发铅和红细胞铅可作为铅接触指标。血浆铅则无意义。     

Systemic effects of two nasally administered glucocorticosteroids

Two topical corticosteroids, budesonide (BUD) and beclomethasone dipropionate (BDP), both administered as suspensions in water, were investigated in healthy volunteers regarding influence on cortisol in plasma and urine (U-cortisol) after nasal application. In the first study, single doses of 200, 400, and 800 μg of BDP and BUD were given at 10:00 pm. In the second study, 100, 200, and 400 μg were given mornings and evenings for 4 days. In the single-dose study, none of the drugs or doses showed any significant influence on cortisol in plasma. However, U-cortisol decreased significantly after BUD 400 and 800 μg. In the multidose study, U-cortisol values were significantly reduced after all doses of BUD and the highest dose of BDP. The compounds tested showed different ability to cause measurable systemic effects after nasal application. The clinical implication is that the prescriber, when choosing a compound, should take the application site into consideration and should also be encouraged to find the lowest effective dose.     

Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan,an AT1-selective non-peptide angiotensin II receptor antagonist

This was a 2-period randomized, crossover study in 8 healthy males to determine the effects of cimetidine (400 mg q.i.d. for 6 days) on the pharmacokinetics and pharmacodynamic effects of the angiotensin II receptor antagonist, losartan (100 mg). Cimetidine increased the AUC for losartan 18% without affecting the AUC for E-3174, the active metabolite of losartan. The increase in plasma renin activity following losartan was not affected by cimetidine (maximum mean increases 12.6 and 12.1 ng Ang I·ml^–1·h^–1 without and with cimetidine, respectively). These results indicate that cimetidine does not appear to alter the pharmacokinetics or pharmacodynamics of losartan to a clinically significant extent.     

猪血清胸腺因子免疫活性的测定

根据哺乳动物循环血液中所含有的血清胸腺因子(STF)能使θ-阴性的玫瑰花瓣状形成细胞(RFC~-)转变成RFC~+,同时提高其对抗θ抗原血清的代用品硫唑嘌呤的敏感性的原理,采用成熟的BALB/C品系小鼠,经摘去胸腺后的鼠脾脏淋巴细胞和绵羊红细胞(SRBC)之间,在STF和硫唑嘌呤同时共存的条件下具有抑制玫瑰花结形成的作用,从而建立了对哺乳动物循环血液中的STF(九肽)的超微量生物活性测定方法。用本方法对猪血清和血浆的检测结果,其活性滴度分别为1:512、1:1024。     

Distinct Expression of Cytokines and Mitogenic Inhibitory Factors in Semen of Fertile and Infertile Men

PROBLEM: To assess the effect of seminal plasma (SP) of fertile and infertile men on leukocyte mitogenic response, and the capability of sperm cells to produce IL-1. METHODS: This study included four groups: fertile men (donors, normal), infertile men with azoospermia (azoo), oligo-terato-asthenozoospermia (OTA), and OTA with genital infection (OTA-inf). Mouse spleen cell proliferation in response to lipopolysaccharide (LPS) or Concanavalin-A (Con-A) was examined in the presence of SP from the above four groups. Supernatants (sup) and lysates (lys) of sperm cells from fertile and oligoteratoasthenospermic (OTA) men were evaluated for IL-1 bioactivity by specific bioassay. RESULTS: Seminal plasma (SP) of the four groups were shown to inhibit the mitogenic response of mouse spleen cells to LPS and Con-A. SP of fertile men was significantly more inhibitory than SP from infertile men. Sperm cells from fertile and OTA infertile men constitutively produced IL-1. Sperm cells of both groups produced similar levels of IL-1 as examined in the supernatants and lysates. CONCLUSIONS: Seminal plasma of fertile men had more inhibitory mitogenic activity than that of OTA. Sperm cells constitutively produce IL-1. It is possible that the factors involved in this inhibition are not only anti-proliferative immune factors. Cytokines and inhibitory factors of mitogenesis in the seminal plasma may be involved in the physiology and pathophysiology of sperm functions and thus affect male fertility.     

白血病患者血浆和外周血白细胞内维生素变化

检测４５例正常人和４４例不同病期白血病血浆和外周血白细胞内维生素Ａ、Ｅ、Ｃ、Ｂ１２和β－胡罗卜素、叶酸浓度。结果表明，初治白血病患者血浆维生素Ａ、β－胡罗卜素降低（Ｐ＜０．０１），未缓期解者血浆β－胡罗卜素和叶酸低于正常（Ｐ＜０．０１和Ｐ＜０．０５）。在初治和未缓解期患者的外周血白细胞内，维生素Ｅ、Ｃ、Ｂ１２和β－胡罗卜素均显著降低（Ｐ＜０．０１～０．００１）。而且，外周血白细胞内维生素代谢异常比血浆更为显著。提示维生素含量变化对于解释病因，预测疗效及估计预后有一定的价值。     

Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia

Abstract: The results of an intensive treatment program for patients 16–60 yr of age with de novo acute myeloid leukemia are presented. The patients were given conventional induction treatment with daunorubicin and cytarabine. Patients not entering complete remission (CR) after 1 course of daunorubicin/cytarabine were given 1 course of amsacrine/etoposide/cytarabine. Those entering complete remission received 3 consolidation courses using mitoxantrone, etoposide, amsacrine and cytarabine. One hundred and eighteen patients were enrolled. Complete remission was attained after 1–2 courses in 90 patients (76%). Another 6 patients reached CR after 3–4 induction courses for a total CR rate of 81%. If feasible, patients were offered either allogeneic or unpurged autologous bone marrow transplantation. Twenty-four patients underwent allogeneic bone marrow transplantation; 15 in first remission, 8 in second remission, 1 in early relapse. Thirty patients below 56 yr of age underwent autologous bone marrow transplantation in first remission. The overall probability of survival at 4 yr was 34%, and for patients below 40 yr of age 50%. Leukemia-free survival was 35% for the whole cohort of patients; 52% for patients below 40 yr of age. Patients undergoing allogeneic or autologous bone marrow transplantation in first remission had an overall survival of 86% and 47%, respectively, while the probability of leukemia-free survival in these groups was 87% vs. 40% at 4 yr. The CR rate and long-term results of this intensive treatment program compare favorably with other recent studies using intensive consolidation with allogeneic or autologous bone marrow transplantation or high dose cytarabine.     

面部色素痣的外科治疗

面部色素痣较常见于鼻、颊、额、颧区，部分病变累及一侧面部的多个区域。这些病变手术切除后的缺损主要采用全厚皮片移植、直接拉拢缝合或邻近皮瓣整复。